The so-called “Plandemic” video is edited in the style of a documentary, with much higher production standards than many conspiracy videos.

The video is filled with medical misinformation about where the virus came from and how it is transmitted.

Despite efforts to remove it, users are constantly re-uploading the clip.

Since the 26-minute video first appeared earlier this week, it has exploded across YouTube, Facebook, Twitter and other websites, prompting an attempt to remove it.

Among its claims are that the virus must have been released from a laboratory environment and could not possibly be naturally-occurring; that using masks and gloves actually makes people more sick; and that closing beaches is “insanity” because of “healing microbes” in the water.

Such claims are not supported by reliable medical and scientific advice.

The video also suggests that the number of deaths is being deliberately falsified, in order to exert control over the population.

• Who spreads ‘fake news’?

• Seven ways to stop bad information

• Covid-19 5G theories top UK misinformation survey

Analysis

By Marianna Spring, specialist disinformation reporter

Scammers, pranksters and politicians have all been guilty of starting misleading rumours - but people passing themselves off as experts in videos like this one have become crucial to the spread of false claims.

Documentary-style films which promote conspiracy theories are increasingly popular, and a marked evolution from the dodgy medical advice being forwarded on WhatsApp at the start of the pandemic.

Slick production means videos often look quite credible initially - before promoting totally false claims. That makes them as dangerous - if not more so - than advice with a mix of truth and misleading medical myths.

The videos often get a lot more attention than content from trusted media outlets, and the controversial experts they feature have amassed their own fan bases. The misinformation they propagate usually serves to undermine information from trusted health bodies and authorities.

It’s a game of cat-and-mouse for social media sites like YouTube, since the same item can be uploaded again and again by different users.

The video has been viewed millions of times across multiple platforms. Facebook, YouTube, and Vimeo have all removed versions of it from their sites.

But such efforts may benefit the film-maker, who claims that there is a large-scale conspiracy to hide the truth.

In a post saying the 26-minute video is an excerpt from a future full-length documentary, he urges readers to download the video directly and re-post it elsewhere, “in an effort to bypass the gatekeepers of free speech”.

Since the pandemic began, the social networks have all had to adapt their content policies to deal with potentially dangerous misinformation.

Twitter said it would remove “unverified claims” that could prove dangerous, while Facebook has brought in new tools to point users towards reliable sources of information.

YouTube said it removes “medically unsubstantiated diagnostic advice”, and this video was removed for making claims about a cure for Covid-19, even though it is not backed by health organisations.

• FACE MASKS: Should I be wearing one?

• VACCINE: How close are we to finding one?

• A SIMPLE GUIDE: How do I protect myself?

• AVOIDING CONTACT: The rules on self-isolation and exercise
  LOOK-UP TOOL: Check cases in your area

Two volunteers were injected, the primary of quite 800 people recruited for the study.

Half will receive the Covid-19 vaccine, and half an impact vaccine which protects against meningitis but not coronavirus.

The design of the trial means volunteers won’t know which vaccine they’re getting, though doctors will.

Elisa Granato, one among the 2 who received the jab, told the BBC: “I’m a scientist, so I wanted to undertake to support the scientific process wherever I can.”

The vaccine was developed in under three months by a team at Oxford University . Sarah Gilbert, professor of vaccinology at the Jenner Institute, led the pre-clinical research.

“Personally I even have a high degree of confidence during this vaccine,” she said.

“Of course, we’ve to check it and obtain data from humans. we’ve to demonstrate it actually works and stops people getting infected with coronavirus before using the vaccine within the wider population.”

Prof Gilbert previously said she was “80% confident” the vaccine would work, but now prefers to not put a figure thereon , saying simply she is “very optimistic” about its chances.
So how does the vaccine work?

The vaccine is formed from a weakened version of a standard cold virus (known as an adenovirus) from chimpanzees that has been modified so it cannot grow in humans.

The Oxford team has already developed a vaccine against Mers, another sort of coronavirus, using an equivalent approach - which had promising leads to clinical trials.
Image caption Fergus holding a vial of the vaccine developed by the Oxford team
How will they know if it works?

The only way the team will know if the Covid-19 vaccine works is by comparing the amount of individuals who get infected with coronavirus within the months ahead from the 2 arms of the trial.

That could be a drag if cases fall rapidly within the UK, because there might not be enough data.

Prof Andrew Pollard, director of the Oxford Vaccine Group, who is leading the trial, said: “We’re chasing the top of this current epidemic wave. If we do not catch that, we cannot be ready to tell whether the vaccine works within the next few months. But we do expect that there’ll be more cases within the future because this virus hasn’t gone away.”

The vaccine researchers are prioritising the recruitment of local healthcare workers into the trial as they’re more likely than others to be exposed to the virus.

A larger trial, of about 5,000 volunteers, will start within the coming months and can haven’t any regulation .

an easy GUIDE: How do I protect myself?
AVOIDING CONTACT: the principles on self-isolation and exercise
WHAT we do not skills to know the price
TESTING: am i able to get tested for coronavirus?
LOOK-UP TOOL: Check cases in your area

Older people tend to possess weaker immune responses to vaccines. Researchers are evaluating whether or not they might need two doses of the jab.

The Oxford team is additionally working with researchers in Kenya a few possible vaccine trial there, where the rates of transmission are growing from a lower base.

If the numbers might be a drag , why not deliberately infect volunteers with coronavirus?

That would be a fast and certain thanks to determine if the vaccine was effective, but it might be ethically questionable because there are not any proven treatments for Covid-19.

But which may be possible within the future. Prof Pollard said: “If we reach the purpose where we had some treatments for the disease and that we could guarantee the security of volunteers, that might be a really great way of testing a vaccine.”
Is it safe?

The trial volunteers are going to be carefully monitored within the coming months. they need been told that some may get a sore arm, headaches or fevers within the first few days after vaccination.

They are also told there’s a theoretical risk that the virus could induce a significant reaction to coronavirus, which arose in some early Sars animal vaccine studies.
Image copyright Sean Elias - Oxford Vaccine trial
Image caption Work began on a vaccine in January

But the Oxford team says its data suggests the danger of the vaccine producing an enhanced disease is minimal, and data from animal studies has been positive.

Scientists there hope to possess a million doses ready by September, and to dramatically proportion manufacturing then , should the vaccine prove effective.
So who would catch on first?

Prof Gilbert says that has not been decided yet: “It’s not really our role to dictate what is going to happen, we just need to attempt to get a vaccine that works and have enough of it then it’ll be for others to make a decision .”

Prof Pollard added: “We’ve need to ensure we’ve enough doses to supply for those in greatest need, not just within the UK but also in developing countries.”
Media captionCoronavirus: what’s a vaccine and the way is one made?

Another team at Imperial College London hopes to start human trials of its coronavirus vaccine in June.

The Oxford and Imperial teams have received quite £40m of state funding.

Health Secretary Matt Hancock has praised both teams and said the united kingdom will “throw everything we’ve got” at developing a vaccine.

UK chief medical adviser Prof Chris Whitty has said neither a vaccine, nor a drug to treat Covid-19, is probably going to be available within subsequent year.

When it involves halting the Covid-19 crisis, virus testing is vital for diagnosing and for tracking the epidemic. It’s the sole thanks to uncover just what percentage people are infected, or could infect others.

Despite how crucial testing is, some countries have much more tests than others – which testing isn’t available to everyone. the rationale comes right down to several factors, including timing, logistics, and therefore the complexity of collecting samples, obtaining the raw materials and equipment for testing, and having the expertise to try to to the tests accurately.

The countries that acted swiftest in terms of testing have also been among the most important successes of the virus’s containment. Take South Korea , which began testing early in clinics, hospitals and drive-through centers. Its first confirmed case was on 20 January 2020. Six weeks later, on 16 March, South Korea was testing 2.13 people per 1,000. Italy, on the opposite hand, which had its first confirmed case on 31 January, was testing 1.65 people per 1,000 six weeks on. Even while Italy ramped up its numbers significantly – it’s now testing a far higher percentage of its population than South Korea , at 24.5 people per 1,000 compared to South Korea’s 11 – the slower start was one factor that made it harder to contain infections overall. (Figures range elsewhere: Spain is currently testing 20 people per 1,000, Australia 17, Canada 15, the US 12 and therefore the UK six.)

You might also like:

• are you able to catch Covid-19 twice?

• The race to create coronavirus ventilators

• what’s Covid-19’s real death rate?

Starting testing later often meant the virus had chance to spread through whole communities by the time testing was implemented. Then came simple economics: as demand spiked, supplies were drained. The countries that reacted slowly required more tests to spot more infections as a result.

A medical professional administers a Covid-19 test in Bolinas, California on 20 April 2020; the town is attempting to check each of its 1,600 residents (Credit: Getty Images)

Testing alone doesn’t cause declines in disease. There are still questions on how reliable test results are for people that are asymptomatic, for instance . and therefore the biggest strides are seen in countries that combined testing with contact tracing and containment measures. Even so, testing allows public health authorities to collect data to form appropriate policy decisions – including about whether more selective or stricter social distancing policies are necessary.

Why ramping up testing is so difficult

Lagging countries are still trying to extend testing capacity. In early April 2020, for instance , the united kingdom Health Secretary announced an initiative to proportion to 100,000 tests each day by the top of April, a ten-fold leap from 10,000 each day at the top of March.

But when it involves Covid-19 tests, scaling up by factors of 10 or 100 isn’t as simple as stocking up when emergency hits.

That’s because the method of accurate Covid-19 testing requires coordination of variety of processes. First, you want to acquire the test kits – the long nasal swabs and chemicals required to process them. These are then sent to expertly-trained laboratory technicians who analyse the samples employing a PCR machine, which may be laborious. and eventually , there must be a system to simply accept samples and report results to the proper people.

Laboratories that were previously doing research only (as against testing for patient care) not only need to run tests accurately – they even have to implement new computer and administrative systems to gather patient information then to distribute the results back to the health care providers.

Making matters more complicated, many countries, including the united kingdom and therefore the US, have had problems getting enough supplies for testing. It’s not such a lot a matter of lacking the raw materials but ensuring they’re pure and mixed within the right amounts. Each brand of test has their own unique blend of about 20 chemicals. Each set requires its own unique packaging. Roche reagents don’t fit a Cepheid any better than a Chevy truck part fits a Prius. Making test kits is as burdensome as drug-making.

Workers prepare components for testing kits in South Korea in March 2020; getting enough supplies for testing has been a challenge for several countries (Credit: Getty Images)

In addition to chemicals, many laboratories lack the government-approved machines. within the US and South Korea , laboratories were allowed to file a so-called Emergency Use Authorisation application. This lets labs develop their own tests supported government protocols, but tweak them consistent with equipment.

As a general rule, the better a test is to perform, the harder it’s to manufacture. the primary Covid-19 tests were simple to form but required specialised expertise. Many early tests take about four hours – two hours of hands-on work, two hours within the machines. Roche and Abbot instruments, available in some academic laboratories, can run 80 to 100 samples at a time. They’re partially automated but still require skilled technicians. Simpler tests that smaller hospital labs can run are hitting the market, but availability is sparse.

Once a laboratory is about up and tests procured, the method can begin – starting with the pre-test.

Pre-test procedure

The pre-test begins with a nasal swab. this is often not a standard cotton ear-bud but an extended , skinny stick that’s flexible enough to increase to the ear. The swab is nylon or foam, not cotton, which inhibits the test.

The nasal swab may be a long, skinny stick that extends to the ear (Credit: Getty Images)

Even procuring those swabs has been difficult because of the crisis. Copan Diagnostics Inc, based in northern Italy, had to receive special government permission to continue production despite the Covid-19 lockdown. Puritan Medical Products, based in Maine, suffered labour shortages.

As a result, nasal swabs are now precious. a couple of entrepreneurs try to form more with 3D printing, but there are teething problems, like any fresh technology. and therefore the vendors are charging 10 times or more what swabs wont to cost.

Once the swab gets to the laboratory, a highly-skilled laboratory technician, wearing an equivalent protective clothing as nurses and doctors, places it into a biosafety hazard box – a glass box with controlled air flow to stop the virus from escaping.

The process is dangerous. Laboratory work generates droplets. only one droplet may contain 1,000,000 approximately viruses which will contaminate the laboratory worker or the laboratory. It also can land in another sample. If that happened, a patient who didn’t have Covid-19 would be told they did.

Laboratory directors love the cooking metaphor. Running a lab test, they say, requires a chef’s attention to detail, measuring precisely each ingredient at the proper time, within the right order and at the proper temperature. But unlike cooking – where a touch little bit of extra spice here or there may enhance the ultimate product, or at the worst case ruin the flavour – a faulty lab test can produce deadly results.

A single droplet being tested can contain 1,000,000 viruses, making it crucial that medical professionals wear full protective gear (Credit: Getty Images)

“One hiccup throws everything off,” said Dr. Kimberle Chapin, professor of pathology, laboratory medicine, and medicine, at the Warren Alpert School of drugs at Brown University and director of microbiology for the Lifespan Academic center , Rhode Island.

Expert technicians with the meticulous skill to run the test are a scarce commodity in many countries.

The testing phase

The testing phase requires two crucial steps. First, extraction – retrieving the potential virus from the muck of the mucus on the swab, and second, detection.

With garbed arms, technologists manipulate samples into tubes to be loaded onto an instrument where chemicals break open the viral coat (the “crown” of the coronavirus), and isolate the pure RNA, one strand of genetic material.

Next, they pipette the RNA into a disc with tiny wells. Each has the reagent that hunts for particular pieces of the Covid-19 viral genome.

The discs are taken to a machine where chemicals multiply short pieces of the viral genome a few billion times. These short pieces are then detected by a fluorescent probe that glows if Covid-19 is there.

An employee holds up a Covid-19 testing kit in Chuncheon, South Korea (Credit: Getty Images)

If the patient’s sample didn’t have the virus, then nothing happens. No multiplication. No glow.

The technologist then checks the controls (the known positive and negative samples that prove the run worked), enters the results into the pc , and calls within the results.

Ensuring accuracy

The only thing worse than no test may be a test that’s wrong. Laboratories can only start testing patients after they need done sufficient studies to make sure reliability. These tests usually take upwards of six weeks, but technicians are working double shifts to hurry the method .

To make matters more complicated, sometimes a patient can test negative even when they’re sick. they’ll have the virus in their lungs, but not release it near the nose where it might stick with the swab. Or, the sample wasn’t obtained correctly.

Of course, this all describes swabbing as a way of checking out a live virus within the patient.

But the newest buzz in testing is that the blood test: the antibody or serology test, which might be wont to establish if someone had the disease within the past and developed immune cells to get over it. It detects one specific a part of a patient’s immune reaction to the disease – the presence of antibodies. it’s hoped these proteins might protect patients from reinfection, although any protection remains to be seen.

Devising an accurate antibody test ushers during a whole new set of challenges. It must make sure that it’s spotting the precise immune cells that fought this particular germ, and not some run-of-the-mill coronavirus, just like the cold . and a few people might get over the disease without ever developing antibodies.

A specialist tests blood samples for Covid-19 in Hanoi, Vietnam (Credit: Getty Images)

Even then, we don’t know enough about Covid-19 yet to understand if infected patients are not any longer susceptible. (Read more about whether you’ll get Covid-19 twice). Nor are there any proven, reliable antibody tests. the united kingdom bought many antibody tests that didn’t work.

If we’ve learned anything thus far , it’s this: we will not ignore the warnings of communicable disease experts who, for many years , are calling for global preparedness for the inevitable new, dangerous viruses. One a part of this preparation includes a worldwide system to rapidly develop, prove, and distribute tests for a replacement virus as soon as possible after it strikes.

Now quite ever, we believe the dedicated laboratory workers most folks will never see and yet are crucial members of the first-responder teams.

Sheldon Campbell, MD, PhD may be a professor of laboratory medicine at Yale and associate chief for the clinical laboratories for the VA Connecticut Healthcare System. Randi Hutter Epstein, MD is that the writer in residence of Yale School of drugs and author of Aroused: The History of Hormones and the way They Control almost Everything.

The new mom says it’s far one of the “worst things” she has visible.

“It become the first time I’d seen my toddler cry tears,” she stated. “I held her, I became crying and we have been just trying to get every other via the situation”.

Born upfront at simply 3lbs 5oz (1.5kg), baby Peyton turned into identified with Covid-19 at just three weeks old.

Her arrival on 26 March - 8 weeks before her due date - defied all of the family’s planning.

Despite feeling healthy, Tracy changed into instructed she may additionally have pre-eclampsia during a ordinary appointment and became despatched instantly to Wishaw General Hospital in Lanarkshire.
Image caption Tracy had no concept she was unwell - and became taken instantly to hospital
‘She’s best - however she has Covid-19’

After those first weeks, for the duration of which Peyton enjoyed a bath in the ward, she began to expose the slightest of symptoms - a sniffle and some coughs, almost undetectable.

Tracy instructed BBC Radio Scotland’s Mornings with Kaye Adams programme the information that her baby had emerge as one of the country’s youngest virus patients become traumatic.

“They stated ‘she’s nice, don’t panic - but she has tested advantageous for coronavirus’,” said Tracy.

"I suppose the medical doctor was looking to maintain me calm but I turned into sobbing.

“As plenty as she became pleasant I idea at what point was she with the virus? How is she fighting in opposition to it when she’s so wee? It changed into just the unknown.”
Image copyright Tracy Maguire
Image caption Tracy and Adrian deliver Peyton a bath inside the days following the Caesarean section

Peyton become given steroids to assist toughen her lungs and received “amazing” care from neonatal nurses within the days that accompanied her diagnosis.

However, after recovering from her Caesarean section, Tracy become informed she would need to go home and isolate for 14 days faraway from her child.

She said: "I turned into pleading on the telephone with the physician announcing I do not need to be faraway from her.

“As lots as anyone became looking after her, I’m her mum. Even if it become the cold, I’d want to be there with her.”

Doctors relented and allowed Tracy to stay - but Adrian would should go domestic and complete the isolation period so that you can see his infant girl.

As days passed, the quantity of deaths in Scotland because of the virus persevered to increase - however Peyton recovered.
Media captionPeyton and her mum featured in BBC filming on the University Hospital Wishaw in Lanarkshire

She and Tracy had been discharged on Monday and Adrian has now held her for the primary time seeing that leaving hospital.

Tracy stated: “From Adrian’s point of view, I think he felt a piece useless - first his baby is coming early and secondly his wife isn’t nicely and he could not be there.”
‘Put your accept as true with in nurses’

Now domestic and settling into a ordinary, Tracy and circle of relatives have praised the docs and nurses at Wishaw General who guided them via a tremendous and daunting birth.
Image copyright Tracy Maguire
Image caption A smiling Peyton who fought off coronavirus just weeks after being born

Tracy said: "They are doing a job this is unreal - they put their life at hazard to ensure my toddler became getting fed and cuddled in their complete PPE.

"It’s spectacular, you’ll by no means recognize how grateful you can be to people. Peyton is my most treasured thing inside the whole international and I trusted them to look after her.

“To any mums which can be worried, put your consider in these nurses.”

The title had previously only been available to Android users outside of the marketplace. It means Google will get a cut of in-game purchases.

Google introduced opt-in security measures which block apps distributed via other means in March.

Epic said the move pushed it to release the game on Google’s platform. Experts suggest the move will benefit players.

Fortnite is one of the world’s most popular video games, attracting millions of players and viewers.

As a “free-to-play game”, its creators make money by selling dance moves, “skins” to change the look of the player’s character, and access to pre-release game modes.

Apple and Google both take a 30% cut of transactions made within apps distributed via their online stores - a fee that Epic chief executive Tim Sweeney had previously described as “disproportionate”.

In the case of Apple’s mobile iOS platform, Epic had no option but to agree, as there is no other easy way to let users install software.

But it had held out against Google until now.

“Google puts software downloadable outside of Google Play at a disadvantage through technical and business measures such as scary, repetitive security pop-ups for downloaded and updated software, restrictive manufacturer and carrier agreements and dealings,” said Epic Games.

“New efforts such as Google Play Protect outright block software obtained outside the Google Play store. Because of this, we’ve launched Fortnite for Android on the Google Play Store.”

Epic Games delays the release of Fortnite's new season
Computer games: More than a lockdown distraction
Fortnite boss says game loot boxes 'cause harm'

One expert said Epic should still benefit in the long run, despite its frustrations.

“Epic has bitten the bullet and released Fortnite on Google Play because there remains a partially untapped audience on Android, especially in markets where smartphone adoption is still increasing,” said Piers Harding-Rolls, games research director at Ampere Analysis.

“Also, the user experience of downloading and updating the game will improve through Google’s first-party services.”
Image copyright Getty Images
Image caption Fortnite has been available to Android phones since August 2018, but had done so without using the Play Store until now

He added that the game had already been downloaded over 50,000 times on the Play Store since its release on Tuesday.

Epic announced last week that it had delayed the release of its third season of Fortnite until June.

It has not explained why, but there has been speculation it could be caused by delays caused by the firm’s staff having to work from home due to the coronavirus pandemic.

The country’s digital minister confirmed the request in an interview given to Bloomberg.

France’s system would let it glean more information about participating smartphone owners than Apple and its partner Google want to allow.

Privacy experts view it as a test case.

“Apple has no reason to agree to this demand and it would open the door to many other requests from other countries and entities,” Prof Olivier Blazy from the country’s University of Limoges, told BBC News.

“As a Frenchman, I think it would be useful to avoid being dependent on the Google-Apple solution but I think it’s strange that the government strategy relies on trying to convince Apple to do something that is against its interest, with no incentive to do so.”

Apple and Google announced on 10 April they were working together to provide a software building-block - known as an application programming interface (API) - that will let authorised Covid-19 contact-tracing apps work more efficiently.

Contact-tracing apps work by logging every time two or more users are close to each other for a substantial period of time.

If one device owner is subsequently diagnosed as being likely to have the virus, an alert can be sent to those they could have infected, who might be asked to self-isolate.

By using such an app in conjunction with other measures, it would in theory be possible to end wider lockdowns and still suppress the disease, so long as enough people take part.

Apple and Google’s method relies on using Bluetooth signals to detect matches.

But they have deliberately designed it so neither they nor the apps’ creators can see who has been given a warning.

The companies have said this is to guarantee “strong protections around user privacy”, which in turn should encourage adoption.

By contrast, Inria - the French institute developing its StopCovid app - has developed a system of its own, called Robert (robust and privacy-preserving proximity tracing protocol).

It published details about it on Sunday on the code-sharing site Github.

Why are there doubts over contact-tracing apps?
NHS contact-tracing app to target 80% of smartphone users
UK confirms plan for its own contact tracing app

And although the French government has promised adoption of the app will be voluntary and involve anonymised data, the document reveals there would be ways to “re-identify users or to infer their contact graphs” if desired.

“It’s a misnomer to call it a privacy-preserving protocol,” said University of Oxford computer scientist Prof Max van Kleek, who prefers the Apple-Google design.

"It does preserve privacy between users but not between the user and the government.

“And that leads to the risk that the government later repurposes the system to make sure that people obey a quarantine or other kinds of things the state might want to know.”

The problem for Inria - and other countries developing their own contact-tracing apps - is Apple currently will not allow Bluetooth-based track-and-tracing to be carried out in the background.

So to work, the apps would have to remain active and on screen, limiting what else owners could do with their handsets and taking an extra toll on battery life.

The developers of Singapore’s TraceTogether app attempted to get round this problem by offering a Power Save mode, which dims the display.
Image copyright Getty Images
Image caption Users have complained about TraceTogether’s need to run in the foreground, in App Store reviews

But users have still complained of being unable to make calls or use other apps at the same time and having accidentally bumped the app into the background when their handset was in their pocket.

And this has discouraged people from using it.

“We’re asking Apple to lift the technical hurdle to allow us to develop a sovereign European health solution that will be tied to our health system,” France’s Digital Minister, Cedric O, told Bloomberg.

Store shelves are empty all over the world, they are rarely available online and even the sellers are asking for reasonable prices, so is the world facing a global shortage of sanitizers?

https://youtu.be/Ngnjw-xidgE
If everyone in the world had a small bottle of sanitizer, we would need 38.5 million liters of sanitizer.

Prior to the Corona virus outbreak, only 3 million liters of sanitizers were manufactured in the world, according to the Arizona Advisory and Intelligence Analysts, and also for personal use only.

The World Health Organization (WHO) says health care workers need 2.9 million liters of sanitizer a month.

New sanitizer factories
The third richest man in the UK has said that he is setting up a hand sanitizer manufacturer in Germany, while in addition he will set up a factory in the UK and provide free to the NHS.

Companies such as Pernood Record, the company that makes absolute vodka, and Diego, the maker of Johnny Walker whiskey, are making sanitizers and providing them to healthcare systems around the world.

Luxury brand LVMH is putting its perfume unit to work.

Image caption Sanitizer has become a must in all kinds of celebrations in the world

Not only are sanitary ware companies unable to meet demand, but they also do not have the alcohol they need to make sanitizers.

If you look for the recommended WHO-recommended sanitizer at Amazon’s global alcohol-based organization, you will find that all the good brands are on sale.

A few days ago only one shopkeeper in the UK had some stock available. A 500 ml bottle was priced at £ 30, which was available ten times less than the Corona virus spread.

• What are the Symptoms of Corona Virus and How to Avoid It?

• What is the difference between corona virus and flu?

• Corona virus: What does social distance and self-loneliness mean?

• Corona virus: Avoid these six fake medical advice

• Corona Virus: Why It’s Not So Hard to Touch the Face
  Pricing

It’s easy to blame these kinds of sellers, and a lot of people have done it, but Hertz Tools, the company that sells it, says it’s not that easy.

When contacted by the company, a friendly person said on the phone: 'We are being unfairly targeted … “There are a lot of people who say we’re making a profit, but I can assure you we’re not.”

Clearly, this was not the first time he had answered such questions.

The company usually used to sell and rent goods for the construction industry and is now selling only sanitizers because consumers are demanding it.

“We are in a position where we are making enough profit from hand sanitizer to keep ourselves alive,” he said.

Image caption The demand for sanitizers is no longer limited to medical institutions and staff

But they have to struggle a lot to get the stock of sanitizer while its price is increasing every day. “We cannot guarantee that the price paid for it today will be met tomorrow,” he said.

And that’s because the price of its main ingredient, alcohol, has risen dramatically.

Hearts Tools is selling a sanitizer developed by a company called Zodiac Laboratories. The company is UK based and makes other skin care products.
Photo copyright PA Media
Image caption The handswash must have at least 70% ethanol for it to be effective.

The Zydac company can produce one million bottles of hand sanitizer a day, but production is declining. The company is not receiving ethanol, which is a component of alcohol, and must have at least 70% ethanol for handwash to be effective.

She receives her ethanol from a network of suppliers. It costs about US $ 800 for a tonne of ethanol and produces 32,000 bottles. These items will be available to them at double the price this week, but they are not sure if they will be shipped or not.
Ten times the price

Last week, a new supplier offered the company 10,000 for a ton of ethanol, ten times the normal price. This company politely declined.

Wesbarth supplies to pharmacies throughout Europe and the Middle East. Now their customers are so reluctant to stock that they are asking them to help provide them with ethanol as well.

The Cyberian tried to contact several distributors of alcohol used in sanitizers in the UK. One woman who answered the phone was almost crying because the company she worked for was shutting down due to lack of stock.
Overwhelmed by demand

Others were so busy and their staff so overwhelmed that they could not speak. A website said that the order door

The outbreak of cod 19 spreads in late 2019. But there are signs that it may take some time for some patients to fully recover.

When a patient recovers from corona depends on the severity of the disease. Some people recover quickly from the disease, but it is possible that some patients have long-term problems.

Your age, sex and health determine how sick you may be with Code 19.

What is the difference between corona virus and flu?

How many Corona patients are there in the world and where?

What are the Symptoms of Corona Virus and How to Avoid It?

Corona virus: Why do deaths vary from country to country?

Corona virus: What is a ventilator and how does it work?

Corona virus: Avoid these six fake medical advice

Can a mask protect you from the corona virus?

How long a person recovers depends on the circumstances under which he or she is being treated.
How long will it take to recover if the symptoms appear less?

Most people infected with Cod 19 show only central symptoms, such as cough and high fever. But they can also feel discomfort, fatigue, sore throat and headaches.

The cough is initially dry, but later some people cough up mucus that contains dead lung cells.

These symptoms are treated by resting in bed, using water or other beverages, and pain relieving medications such as paracetamol.

People with mild symptoms recover more quickly.

Their fever goes away in less than a week, but the cough may last for a while. With information from China, the World Health Organization says recovery could take up to two weeks.
What if the symptoms were more pronounced?

For some people, the disease becomes very dangerous and occurs seven to 10 days after infection.
Image copyright Getty Images

This change can happen suddenly. Difficulty breathing and swelling in the lungs. This is because the body’s immune system is trying to fight the virus. It reacts excessively, which is also harming the body.

Some people have to be hospitalized to get more oxygen.

“It can take some time for a respiratory problem to heal, and in the meantime the body recovers from the swelling and other effects,” says General Physician Sarah Jarvis.

She says it can take two to eight weeks to recover. Fatigue lasts longer.
When does intensive care are needed?

According to the World Health Organization, one out of 20 patients with the Corona virus requires the utmost care in treatment. This includes fainting and the use of ventilators.

It takes some time to fully recover after being in the ICU (Intensive Care Unit), no matter what illness you have. Patients are admitted to the general ward from the ICU before being sent home.

Extensive care medicine expert Dr. Allison says it can take 12 to 18 months for full recovery after the ICU.

Spending more time in a hospital bed can help you lose muscle weight. Patients become weak and it may take time for them to regain their health. Some people may need physiotherapy to get back on track.

Spending time in the ICU can cause changes in the body and may also lead to psychological problems.

“The disease carries with it an additional burden,” says Dr. Paul, a cardiologist at Cardiff and the Vail University Health Board. Fatigue due to the virus is an important aspect.

There have been reports from China and Italy that the patient’s whole body becomes weak after healing, he has shortness of breath, coughs and has difficulty breathing. In addition, they get a lot of sleep.

“We know that patients need a lot of time to recover, possibly a few months.”

But it is difficult to allocate this period to everyone. Some people spend less time in intensive care while others have to be kept on a ventilator for several weeks.
Image copyright Getty Images
Image caption In France, the Corona virus-infected person strives for full recovery
Can Corona Virus Have Long-Term Effects?

There is currently no long-term information regarding the Corona virus. But we can compare it to other diseases.

Patients with lung damage due to immune system response may have ‘breathing difficulties’.

According to physiotherapist Paul, the data show that people can experience physical and psychological problems up to five years later.

General Physician Dr. James Gill says people also need help to improve their mental health.

'You’re having trouble breathing. Then the doctor says, “We have to put you on a ventilator.” You have to sleep. Do you want to say goodbye to your family? ’

PTSD (or trauma) is not uncommon in patients with this type of anxiety. For many, it had psychotic symptoms

Perhaps Artificial Intelligence is a bit overstated. But when it comes to medicine, there is a proven record of how useful artificial intelligence has been in this field.

So can artificial intelligence help with the challenge of discovering the cure for this dangerous disease?

Many companies are in the race to solve this problem.

Accenta, a company based in Oxford, which first tested humans with artificial intelligence, is busy researching 15,000 drugs at the Scripps Research Institute in California.

Helix, a Cambridge company founded by Viagra co-creator Dr. David Brown, has turned the artificial intelligence system to finding medicines for uncommon ailments. Now their goal is to discover Corona’s treatment.

The system is divided into three parts:

• Review all current literature literature

• To study the DNA’s DNA structure and structure

• Evaluate the fit of different medicines

The drug discovery process has traditionally been quite slow.

Dr. Brown told BBC News, ‘I’ve been doing this for 45 years and so far I’ve only been able to bring three medicines to market.’

But artificial intelligence is proving very fast.

“It has taken us several weeks to gather the required data and we have also received new information in the last few days so we have a large amount of data,” says Dr. Brown.

“The algorithm was run on Easter and in the next seven days we will have the results of all three procedures,” he explains.

Helix hopes that in light of this information, he will make a list of possible drugs by May and he is discussing laboratories for his clinical trials.

When it comes to the Corona virus, there are two ways for those seeking treatment with artificial intelligence:

• Looking for a completely new drug but having to wait a few years to approve its safe use
• Rejuvenating existing medicines with a new purpose

But Dr. Brown said there was absolutely no possibility that the cure could be cured with a single drug.

For Helix, this means a detailed analysis of eight million potential pairs and 10.5 billion collections of medicines made possible with over 4,000 approved medicines in the market.

“Artificial intelligence is one of the strongest paths we have to achieve a viable drug,” Professor Ara Tarazi, director of the Institute of Global Health Innovation at Imperial College, told BBC News. But the basic requirement for this is a set of high quality, large and clear data. ’

“To date, much of this information has been sent to individual companies, such as large pharma companies or these have been lost in old laboratories within universities.”

“Now more than ever, there is a need to combine data sources involved in the discovery of these proportional materials, so that researchers of artificial intelligence are using their new machine learning techniques to discover the treatment of Cod-19 as soon as possible.” Can do. ’

Barabasi Laboratory of North Eastern University in the United States, Harvard Medical School, Stanford Network Science Institute and Biotech start-up Shaffer Madison, all looking for a drug that has been re-developed as a treatment for Cod-19. Can go

Amazing discovery

Alf Saleh, chief executive of Shaffer, said it would normally take ‘a year in the paperwork’ to work together.

“But with people who have the ability to make the work logical and have the time, a whole series of zoom calls can be made to speed up the process.”

He says’ the work done in the last three weeks usually takes half a year. Everyone has paid attention to everything else. ’

And the amazing results of their research are starting to emerge. Including:

• The suggestion that the virus may be invading brain cells, causing some people to lose a sense of taste or smell.

• It is predicted that the virus could also attack the reproductive system of both males and females

Shaffer Madison combines artificial intelligence with something they call Network Medicine. It is a method of visualizing a disease through a complex interaction between molecular components.

Saleh says, 'The disease that comes to us is rarely due to a single gene or protein defect. Nature is not so easy. Rather, it is the result of a clash between multiple proteins. ’

Consortium has identified 81 potential drugs that may be helpful, using Network Medicine, artificial intelligence and the fusion of both.

Professor Albert Laszlo Barabasi says, ‘Artificial intelligence can do a lot of good work, not only to improve the order, but also to look for free information that may not go beyond network medicine.’

But artificial intelligence can’t do it alone, it requires all three of these methods.

He adds, ‘Different tools see things from different perspectives, but together they become very powerful.’

Some artificial intelligence companies are already claiming that they have identified some drugs that may be helpful.

Benevolent artificial intelligence has identified ‘baristinib’ as a potential cure for the prevention of a virus affecting lung cells, leading to inflammation of the bones (which causes inflammation in the joints of water in the joints). Is a medicine approved for treatment.

And now controlled trials are being conducted at the US Institute for Allergy and Infectious Diseases.

Meanwhile, scientists from South Korea and the US have used Deep Learning to highlight their research using commercially available anti-viral drugs such as azinavir (a drug used to treat AIDS). Is.

Other companies are using artificial intelligence for other purposes, such as analyzing scans to reduce the burden on radiologists and helping predict which patients will need more ventilators.

For example, Chinese technology guru Alibaba announced an algorithm that can diagnose people infected with the virus within 20 seconds, with 96% accurate results.

But some experts warn that it is hardly possible that artificial intelligence systems have been trained on advanced disease statistics, and therefore may not be so effective at detecting early signs of the virus. Yes

Professor Darzi said that policy makers globally should try to convince large pharmaceutical companies, academics and research charities to work together using their data sources.

They say, ‘There could be no better chance to share data and discover the secrets of technology to help artificial intelligence in the fight against Cod-19.’